Medical Health & Life Science Research News

At 10.2% CAGR growth of competent cells market to hit $2.22 bn by 2022 detailed in new research report

The competent cells market is segmented on the basis of type, application, and end user. On the basis of type, the competent cells market is segmented into chemically competent cells and electrocompetent cells.

- Agency -.

Global Competent cells Industry was valued at $1.37 Billion in 2017 & projected to surge at a CAGR of 10.2% to hit $2.22 Billion by 2022.

 

Download Sample Research Report Now @

www.rnrmarketresearch.com/contacts…amp;utm_source=pp

Advancements in molecular cloning research due to the emergence of new technologies and increasing commercial demand for molecular cloned products and recombinant proteins are the major factors driving the growth of the competent cells market.

Key players operating in the competent cells market include Merck KGaA (Germany) Promega Corporation (U.S.), Thermo Fisher Scientific, Inc. (U.S), New England Biolabs (U.S.), Takara Bio (Japan), Agilent Technologies (U.S.), Lucigen (Epicenter) (Illumina) (U.S.), QIAGEN N.V.

- Agency -.

(Germany), OriGene Technologies (U.S.), Bioline (U.K.), Zymo Research (U.S.), Beijing TransGen Biotech Co., Ltd. (China), Source BioScience (U.K.), IBA GmBH (Germany), Genewiz (U.S.), BioDynamics Laboratory, Inc.

(Japan), GCC Biotech (India), SMOBIO Technology (Taiwan), GeneScript Corporation (U.S.), Bio-Rad Laboratories (U.S.), Life Technologies (India) Pvt. Ltd., Cell Applications, Inc. (U.S.), Delphi Genetics (Belgium), Scarab Genomics, LLC (U.S.), and Yeastern Biotech Co., Ltd.

(Taiwan).

North America to account for the largest share of the market

Geographically, the competent cells market is dominated by North America, followed by Europe. The North American region is estimated to account for the largest share in 2017, and the trend is expected to continue during the forecast period.

The growth in this market can be attributed to the presence of major key players in the region, technological advancements, growth in the biotechnology and pharmaceutical industries, and increasing inclination towards research based on genomics and proteomics.

 

The primary interviews conducted for this report can be categorized as follows:

  1. By Company Type - Tier 1 – 25 %, Tier 2 – 35% and Tier 3 – 40%
  2. By Designation – C-level – 35%, Director-level – 25%, Others – 40%
  3. By Region – North America - 43%, Europe – 19%, APAC – 29%, RoW – 9%

 

Access complete report on @

www.rnrmarketresearch.com/contacts…amp;utm_source=pp

 

Target Audience for this Report:

  1. Competent cell manufacturers
  2. Research instrument manufacturers
  3. Competent cell distributors
  4. Various research and consulting companies
  5. Research laboratories and research institutes
  6. Universities and CROs

Increasing intensity of research and technological advancements drives growth of the other applications Based on application, the global competent cells market is broadly segmented into cloning, protein expression, and other applications. The other applications segment is expected to register the highest CAGR during the forecast period.

This segment comprises of mutagenesis, single-stranded DNA production, lent viral vector production, and large plasmid transformation. The growth in this segment is primarily attributed to increasing intensity of research and technological advancements.

Browse complete report on Competent Cells Market by Type (Chemically, Electrocompetent), Application (Subcloning, Phage Display Library Production, Unstable DNA Cloning, High-Throughput Cloning, Mutagenesis), End User (Pharmaceutical Companies, Academia) - Global Forecast to 2022 with 101 Market Data Tables and 39 Figures spread through 159 Pages and in-depth TOC on

Now available at www.rnrmarketresearch.com/competen…arket-report.html

The competent cells market is segmented on the basis of type, application, and end user. On the basis of type, the competent cells market is segmented into chemically competent cells and electrocompetent cells.

The chemically competent cells segment is expected to command the largest share of the global competent cells market in 2017. However, the electrocompetent cells segment is expected to grow at the highest CAGR during the forecast period.

Electrocompetent cells offer high transformation efficiencies, making them suitable for many molecular biology applications such as the generation of cDNA libraries or constructing gene banks.

Other applications are further subsegmented into mutagenesis, single-stranded DNA production, lentiviral vector production, and large plasmid transformation. The other applications segment is expected to grow at the highest CAGR during the forecast period.

This segment is primarily driven by the increasing intensity of research and technological advancements in competent cells. In addition, the growth in the genomics market will enhance research in mutagenesis, thus driving the demand for competent cells.

News From

RnR Market Research - Market Research and Competitive Analysis ReportsRnR Market Research
Category: Market Research Publishers and RetailersCompany profile: RnRMarketResearch.com is an online database of market research reports offers in-depth analysis of over 5000 market segments. The library has syndicated reports by leading market research publishers across the globe and also offer customized market research reports for multiple industries.